Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.

about

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.

Item

http://www.wikidata.org/entity/Q41594853

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Role of adjuvant chemotherapy ...... radiation therapy and surgery.

@en

type

Item

label

Role of adjuvant chemotherapy ...... radiation therapy and surgery.

@en

prefLabel

Role of adjuvant chemotherapy ...... radiation therapy and surgery.

@en

P1476

Role of adjuvant chemotherapy ...... oradiation therapy and surgery

@en

P2093

Byung Soh Min

http://www.w3.org/2001/XMLSchema#string

Chan Kim

http://www.w3.org/2001/XMLSchema#string

Chang Gon Kim

http://www.w3.org/2001/XMLSchema#string

Hoguen Kim

http://www.w3.org/2001/XMLSchema#string

Hyung Soon Park

http://www.w3.org/2001/XMLSchema#string

Inkyung Jung

http://www.w3.org/2001/XMLSchema#string

Jee Hung Kim

http://www.w3.org/2001/XMLSchema#string

Minkyu Jung

http://www.w3.org/2001/XMLSchema#string

Nam Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Seung Hoon Beom

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative adjuvant chemotherapy in rectal cancer operated for cure

New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P2888

s12885-017-3624-7

P304

615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3624-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091422894

http://www.w3.org/2001/XMLSchema#string

P698

28865435

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5581409

http://www.w3.org/2001/XMLSchema#string